Back
Prelude Therapeutics Gains FDA Approval for Cancer Drug Trial
Back
Stock News
Themes
Prelude Therapeutics Gains FDA Approval for Cancer Drug Trial
Prelude Therapeutics Gains FDA Approval for Cancer Drug Trial
Edgen Stock
·
Feb 03 2026, 16:16
Share to
Share to
Copy link
PRLD
+0.93%
source:
[1] Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
Recommend
China Liberal Education Hit With Class-Action Investor Lawsuit
Feb 19 2026, 15:59
US Home Sales Fall 8.4% Signaling Market-Wide Cooldown
Feb 19 2026, 15:58
Fed's Kashkari Accuses White House of Compromising Central Bank Independence
Feb 19 2026, 15:58
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Feb 03 2026, 16:16Edgen Stock·Feb 03 2026, 16:16
Edgen Stock·Feb 03 2026, 16:16